Your browser doesn't support javascript.
loading
Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor.
Ved, Kieran J; Bhatt, Arjun; Burke, Aidan M; Larkins, Michael C; Pandya, Dishita; Marcu, Constantin B.
Afiliação
  • Ved KJ; Brody School of Medicine, East Carolina University Greenville North Carolina USA.
  • Bhatt A; Brody School of Medicine, East Carolina University Greenville North Carolina USA.
  • Burke AM; Department of Radiation Oncology, Brody School of Medicine East Carolina University Greenville North Carolina USA.
  • Larkins MC; Brody School of Medicine, East Carolina University Greenville North Carolina USA.
  • Pandya D; Department of Cardiovascular Sciences, Brody School of Medicine East Carolina University Greenville North Carolina USA.
  • Marcu CB; Department of Cardiovascular Sciences, Brody School of Medicine East Carolina University Greenville North Carolina USA.
Clin Case Rep ; 12(3): e8622, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38449894
ABSTRACT
Radioligand Therapy (RLT) in the form of [177Lu] Lu-DOTA-TATE (Lutathera®) is a promising treatment for pancreatic neuroendocrine tumors (pNETs) with cardiac metastasis. We present a patient treated with [177Lu] Lu-DOTA-TATE that showed shrinkage of metastasis after four treatments at 7.4 GBq every 8 weeks.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Case Rep Ano de publicação: 2024 Tipo de documento: Article